Genoray Co. Ltd (KQ:122310) — Market Cap & Net Worth
Market Cap & Net Worth: Genoray Co. Ltd (122310)
Genoray Co. Ltd (KQ:122310) has a market capitalization of $27.66 Million (₩40.82 Billion) as of September 16, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24155 globally and #1700 in its home market, demonstrating a 1.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genoray Co. Ltd's stock price ₩3360.00 by its total outstanding shares 12147346 (12.15 Million). Also see 122310 total assets for a full breakdown of the balance sheet.
Genoray Co. Ltd Market Cap History: 2018 to 2026
Genoray Co. Ltd's market capitalization history from 2018 to 2026. Data shows change from $48.50 Million to $27.66 Million (-13.46% CAGR). Also see Genoray Co. Ltd (122310) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Genoray Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$231.82 Billion | 0.01% | #873 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$231.82 Billion | 0.01% | #873 of 1384 |
Weight: Genoray Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Genoray Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genoray Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Genoray Co. Ltd (122310) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Genoray Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.05x
Genoray Co. Ltd's market cap is 0.05 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $48.50 Million | $56.29 Billion | $9.47 Billion | 0.00x | 0.01x |
| 2019 | $56.41 Million | $65.11 Billion | $13.24 Billion | 0.00x | 0.00x |
| 2020 | $75.44 Million | $61.69 Billion | $10.17 Billion | 0.00x | 0.01x |
| 2021 | $77.97 Million | $74.29 Billion | $14.32 Billion | 0.00x | 0.01x |
| 2022 | $62.22 Million | $82.60 Billion | $13.90 Billion | 0.00x | 0.00x |
| 2023 | $56.27 Million | $97.90 Billion | $12.49 Billion | 0.00x | 0.00x |
| 2024 | $45.28 Million | $106.98 Billion | -$1.80 Billion | 0.00x | N/A |
| 2025 | $34.25 Million | $108.04 Billion | $757.69 Million | 0.00x | 0.05x |
Competitor Companies of 122310 by Market Capitalization
Companies near Genoray Co. Ltd in the global market cap rankings as of September 16, 2026. Review 122310 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Genoray Co. Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Genoray Co. Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Genoray Co. Ltd's market cap moved from $48.50 Million to $ 27.66 Million, with a yearly change of -13.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩27.66 Million | -19.23% |
| 2025 | ₩34.25 Million | -24.36% |
| 2024 | ₩45.28 Million | -19.54% |
| 2023 | ₩56.27 Million | -9.56% |
| 2022 | ₩62.22 Million | -20.20% |
| 2021 | ₩77.97 Million | +3.35% |
| 2020 | ₩75.44 Million | +33.73% |
| 2019 | ₩56.41 Million | +16.30% |
| 2018 | ₩48.50 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Genoray Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.66 Million USD |
| MoneyControl | $27.66 Million USD |
| MarketWatch | $27.66 Million USD |
| marketcap.company | $27.66 Million USD |
| Reuters | $27.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genoray Co. Ltd
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded … Read more